Agilent Technologies, Inc. $A Shares Sold by Rhumbline Advisers

Rhumbline Advisers decreased its holdings in shares of Agilent Technologies, Inc. (NYSE:A) by 5.4% during the third quarter, according to its most recent disclosure with the SEC. The fund owned 527,352 shares of the medical research company’s stock after selling 29,828 shares during the period. Rhumbline Advisers owned approximately 0.19% of Agilent Technologies worth $67,686,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently modified their holdings of A. Vanguard Group Inc. grew its position in Agilent Technologies by 1.8% during the 2nd quarter. Vanguard Group Inc. now owns 33,997,845 shares of the medical research company’s stock worth $4,012,086,000 after purchasing an additional 589,219 shares during the last quarter. Massachusetts Financial Services Co. MA raised its holdings in shares of Agilent Technologies by 10.7% in the second quarter. Massachusetts Financial Services Co. MA now owns 13,227,387 shares of the medical research company’s stock worth $1,560,964,000 after buying an additional 1,273,994 shares during the last quarter. Geode Capital Management LLC lifted its stake in shares of Agilent Technologies by 1.6% during the second quarter. Geode Capital Management LLC now owns 7,319,530 shares of the medical research company’s stock worth $860,137,000 after buying an additional 115,183 shares during the period. Generation Investment Management LLP grew its holdings in shares of Agilent Technologies by 15.9% during the second quarter. Generation Investment Management LLP now owns 5,775,860 shares of the medical research company’s stock valued at $681,609,000 after buying an additional 792,304 shares during the last quarter. Finally, Norges Bank acquired a new position in shares of Agilent Technologies in the 2nd quarter valued at $395,088,000.

Insider Activity

In other Agilent Technologies news, VP Rodney Gonsalves sold 3,000 shares of the stock in a transaction that occurred on Wednesday, November 26th. The stock was sold at an average price of $154.99, for a total transaction of $464,970.00. Following the transaction, the vice president owned 31,846 shares in the company, valued at approximately $4,935,811.54. This represents a 8.61% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO Padraig Mcdonnell sold 911 shares of the firm’s stock in a transaction that occurred on Tuesday, November 18th. The shares were sold at an average price of $143.24, for a total value of $130,491.64. Following the completion of the sale, the chief executive officer directly owned 32,058 shares in the company, valued at approximately $4,591,987.92. The trade was a 2.76% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing.

Analysts Set New Price Targets

A number of brokerages have commented on A. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Agilent Technologies in a research report on Monday, December 29th. JPMorgan Chase & Co. lifted their target price on Agilent Technologies from $165.00 to $180.00 and gave the stock an “overweight” rating in a report on Tuesday, November 25th. HSBC assumed coverage on shares of Agilent Technologies in a report on Tuesday, January 20th. They issued a “buy” rating and a $180.00 price target on the stock. Evercore upgraded shares of Agilent Technologies from an “in-line” rating to an “outperform” rating and lifted their price objective for the company from $155.00 to $160.00 in a research note on Monday, January 5th. Finally, Morgan Stanley assumed coverage on shares of Agilent Technologies in a report on Tuesday, December 2nd. They issued an “overweight” rating on the stock. Two equities research analysts have rated the stock with a Strong Buy rating, eleven have given a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat, Agilent Technologies presently has a consensus rating of “Moderate Buy” and an average price target of $164.50.

Agilent Technologies Trading Down 3.1%

Shares of NYSE:A opened at $124.86 on Friday. Agilent Technologies, Inc. has a 12-month low of $96.43 and a 12-month high of $160.27. The company has a market capitalization of $35.32 billion, a PE ratio of 27.32, a PEG ratio of 3.74 and a beta of 1.30. The business has a 50 day moving average of $138.23 and a two-hundred day moving average of $135.25. The company has a current ratio of 1.96, a quick ratio of 1.52 and a debt-to-equity ratio of 0.45.

Agilent Technologies (NYSE:A) last issued its quarterly earnings data on Monday, November 24th. The medical research company reported $1.59 EPS for the quarter, topping analysts’ consensus estimates of $1.58 by $0.01. Agilent Technologies had a net margin of 18.75% and a return on equity of 25.20%. The business had revenue of $1.86 billion for the quarter, compared to analysts’ expectations of $1.83 billion. During the same quarter last year, the company earned $1.46 EPS. The business’s revenue was up 9.4% on a year-over-year basis. Agilent Technologies has set its Q1 2026 guidance at 1.350-1.380 EPS and its FY 2026 guidance at 5.860-6.000 EPS. As a group, analysts forecast that Agilent Technologies, Inc. will post 5.58 EPS for the current year.

Agilent Technologies Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 22nd. Shareholders of record on Tuesday, March 31st will be given a $0.255 dividend. The ex-dividend date is Tuesday, March 31st. This represents a $1.02 dividend on an annualized basis and a dividend yield of 0.8%. Agilent Technologies’s dividend payout ratio is 22.32%.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.